Skip to main navigation
Skip to search
Skip to main content
The University of Aberdeen Research Portal Home
Help & FAQ
Home
Profiles
Disciplines
Research output
Research Facilities
Datasets
Impacts
Activities
Press/Media
Prizes
Projects
Search by expertise, name or affiliation
Thalidomide: the drug with a dark side but an enigmatic future
Neil Vargesson
Medical Sciences
Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)
Research output
:
Contribution to specialist publication
›
Article
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Thalidomide: the drug with a dark side but an enigmatic future'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Thalidomide
100%
Birth Defects
50%
Long Bone
50%
Sedative
50%
Early Pregnancy
50%
Morning Sickness
50%
Phocomelia
50%
Pharmacology, Toxicology and Pharmaceutical Science
Thalidomide
100%
Phocomelia
50%
Congenital Malformation
50%
Side Effect
50%
Morning Sickness
50%